Application 020592

Type
NDA
Sponsor
LILLY

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ZYPREXAOLANZAPINETABLET;ORAL2.5MGYesNo
002ZYPREXAOLANZAPINETABLET;ORAL5MGYesYes
003ZYPREXAOLANZAPINETABLET;ORAL7.5MGYesNo
004ZYPREXAOLANZAPINETABLET;ORAL10MGYesNo
005ZYPREXAOLANZAPINETABLET;ORAL15MGYesNo
006ZYPREXAOLANZAPINETABLET;ORAL20MGYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0002-4112ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4112ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4112ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4112ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4112ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4112ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4115ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4115ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4115ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4115ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4115ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4115ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4116ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4116ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4116ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4116ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4116ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4116ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4117ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4117ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4117ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4117ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4117ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4117ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4415ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4415ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4415ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4415ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4415ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4415ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4420ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4420ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4420ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4420ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4420ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
0002-4420ZyprexaOlanzapineEli Lilly and CompanyNDACurrent
21695-140ZyprexaOlanzapineRebel Distributors CorpNDACurrent
21695-142ZyprexaOlanzapineRebel Distributors CorpNDACurrent
21695-144ZyprexaOlanzapineRebel Distributors CorpNDACurrent
49999-606ZyprexaOlanzapineLake Erie Medical DBA Quality Care Products LLCNDACurrent
52959-579ZyprexaOlanzapineH.J. Harkins Company, Inc.NDACurrent
55289-213ZyprexaOlanzapinePD-Rx Pharmaceuticals, Inc.NDACurrent
68258-7090ZyprexaOlanzapineDispensing Solutions, Inc.NDACurrent
68258-7091ZyprexaOlanzapineDispensing Solutions, Inc.NDACurrent
68258-7092ZyprexaOlanzapineDispensing Solutions, Inc.NDACurrent
68258-7093ZyprexaOlanzapineDispensing Solutions, Inc.NDACurrent
70518-1465ZyprexaOlanzapineREMEDYREPACK INC.NDACurrent
70518-1465ZyprexaOlanzapineREMEDYREPACK INC.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84950SUPPL 2026-02-05
84889SUPPL 2026-02-03
84951SUPPL 2026-01-30
81159SUPPL 2025-02-07
80957SUPPL 2025-02-05
62676SUPPL2020-04-24
62663SUPPL2020-04-24
62662SUPPL2020-04-24
62635SUPPL2020-04-22
62634SUPPL2020-04-22
62629SUPPL2020-04-22
60660SUPPL2019-10-24
60657SUPPL2019-10-24
60635SUPPL2019-10-23
53520SUPPL2018-03-29
53472SUPPL2018-03-28
47377SUPPL2017-03-02
47376SUPPL2017-03-02
47347SUPPL2017-02-27
47346SUPPL2017-02-27
45532SUPPL2016-10-14
45600SUPPL2016-10-07
34914SUPPL2015-07-24
12799SUPPL2015-01-09
2817SUPPL2014-12-23
12800SUPPL2013-07-30
2818SUPPL2013-07-30
41458SUPPL2012-03-16
41457SUPPL2012-03-16
41455SUPPL2012-03-16
20747SUPPL2012-03-16
20749SUPPL2012-01-27
44059ORIG2011-12-22
41456SUPPL2011-06-30
20748SUPPL2011-06-30
34913SUPPL2011-06-29
12798SUPPL2011-06-29
25267SUPPL2011-06-27
25266SUPPL2011-06-27
44452SUPPL2011-01-07
25265SUPPL2010-12-06
12797SUPPL2010-12-04
34912SUPPL2010-06-03
34911SUPPL2010-06-03
25264SUPPL2010-06-03
2816SUPPL2010-06-03
25263SUPPL2010-02-01
34910SUPPL2010-01-29
25260SUPPL2010-01-26
2813SUPPL2010-01-26
12794SUPPL2009-12-10
12793SUPPL2009-12-10
25262SUPPL2009-11-19
34909SUPPL2009-09-17
20746SUPPL2009-09-16
20745SUPPL2009-09-16
34908SUPPL2009-03-20
2815SUPPL2008-08-19
20743ORIG2007-11-19
25261SUPPL2007-07-10
12796SUPPL2007-07-10
12795SUPPL2007-07-10
2814SUPPL2007-07-10
41454SUPPL2007-07-06
20744SUPPL2007-04-11
25259SUPPL2006-12-28
34907SUPPL2006-12-04
2809SUPPL2006-09-18
34905SUPPL2006-08-29
2812SUPPL2006-03-01
34906SUPPL2006-02-28
25258SUPPL2006-02-22
12792SUPPL2006-02-22
12791SUPPL2006-02-22
2810SUPPL2006-02-22
2811SUPPL2005-09-15
25257SUPPL2005-08-08
25256SUPPL2005-06-29
41453SUPPL2004-04-15
12790SUPPL2004-01-22
2808SUPPL2004-01-22
2807SUPPL2003-07-28
34904SUPPL2003-07-10
52115SUPPL1900-01-01
52114SUPPL1900-01-01
52113SUPPL1900-01-01
52111SUPPL1900-01-01
52110SUPPL1900-01-01
52109SUPPL1900-01-01